European Pharmaceutical Review

MARCH 5, 2024

International participation and trending topics With over 900 exhibitors, analytica 2024 promises an impressive lineup. analytica 2024 provides a comprehensive overview of innovative analytics and molecular – as well as microbiological – testing methods. Top topics at the trade fair include digitalisation, Laboratory 4.0,

Consulting 98

Consulting Pharmaceutical Transportation Safety 98

European Pharmaceutical Review

APRIL 18, 2024

These results for the antibiotics treatment will be presented at the 2024 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global at the end of the month. The post Antibiotic demonstrates non-inferiority to a leading gonorrhoea treatment appeared first on European Pharmaceutical Review.

Leads 105

Leads Safety Patients Pharmaceutical 105

Curzon Consulting

FEBRUARY 29, 2024

29th February 2024 1 Minutes We are delighted to have been recognised again as one of the ‘UK’s Leading Management Consultants 2024’ by the Financial Times Recommended across 11 categories an increase from 8 in 2023, the annual rating, compiled with data company Statista is based on endorsements by clients and peers.

Consulting 52

Consulting Leads Management Healthcare 52

Referral MD

NOVEMBER 1, 2024

1, 2024 /PRNewswire-PRWeb/ — ReferralMD, a leader in healthcare technology solutions, announced today that it was recognized as a 2024 Top Company in Conversational AI upon the conclusion of extensive research and company outreach by AVIA Marketplace, the leading digital health marketplace. PLEASANT, S.C. , Nov.

Healthcare 105

Healthcare Healthcare Management CRM 105

Fierce Pharma

MARCH 28, 2024

[Yangzhou, China - March 26, 2024] - Aurisco Pharmaceutical, a leading global pharmaceutical company, is excited to announce the completion of its investment in cGMP peptide manufacturing capacity | Aurisco Pharmaceutical Launches State-of-the-Art Manufacturing Facility for GLP-1 Peptides

Manufacturing 147

Manufacturing Pharmaceutical Leads 147

Copyright Clearance Center

FEBRUARY 1, 2024

. – CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, announces that its President and CEO, Tracey Armstrong , was named a winner of the 2024 BIG Innovation Award recognizing organizations, products, and people bringing new ideas to life in innovative ways and presented by Business Intelligence Group.

Leads 98

Leads Management 98

European Pharmaceutical Review

AUGUST 15, 2023

CPHI, the global pharmaceutical event that spans the entire supply chain from ingredients and finished dosages to machinery, bio, and packaging will return to Fiera Milano (Rho) in 2024. The post CPHI to return to Milan in 2024 appeared first on European Pharmaceutical Review.

Manufacturing 98

Manufacturing Pharma Pharmaceutical Pharmaceutical research 98

European Pharmaceutical Review

FEBRUARY 26, 2024

At its February 2024 meeting, the EMA’s human medicines committee (CHMP) recommended the extension of marketing authorisations for six treatments, and positive opinions for the approval of ten medicines. CHMP meeting highlights: January 2024 The post CHMP meeting highlights: February 2024 appeared first on European Pharmaceutical Review.

Medicine 98

Medicine Patients Marketing Pharmaceutical 98

Copyright Clearance Center

MARCH 5, 2024

March 5, 2024 – Danvers, Mass. – CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, will host, “ Publishers, Copyright & AI: Taking Action ” at the 2024 London Book Fair on Tuesday, 12 March, 10:30 – 11:00am GMT in the Tech Theatre.

Training 98

Training Media Leads 98

MedCity News

JULY 10, 2023

A Phase 3 test of the nanoparticle-based therapy is expected to yield preliminary data in 2024. Johnson & Johnson is committing up to $60 million for global rights to a Nanobiotix therapy that enhances radiation treatment for head and neck cancer.

Leads 96

Leads Biopharma Pharma 96

Copyright Clearance Center

NOVEMBER 1, 2024

The Women’s Edge and Globe Magazine celebrate the state’s leading companies and nonprofit organizations led by women.

Leads 98

Leads 98

MedCity News

APRIL 20, 2023

A lead program with preclinical proof-of-concept data in small cell lung cancer is on track to reach the clinic in 2024. Abdera Therapeutics emerged from stealth with technology that improves the way antibodies deliver radiopharmaceuticals for cancer.

Leads 120

Leads Biopharma Pharma 120

Healthcare Success

JANUARY 2, 2024

Now that the holidays have drawn to a close, it’s time to return to your 2024 marketing plan and make adjustments that ensure your business is taking advantage of the latest trends in healthcare marketing to reach patients and HCPs more effectively and make a lasting impression. This helps improve click-through and conversion rates.

Healthcare 78

Healthcare Healthcare Marketing Healthcare Provider 78

Contrarian Sales Techniques

DECEMBER 31, 2023

Innovative Sales Techniques : We delved into various innovative sales techniques, from leveraging social media for lead generation to integrating AI-powered analytics for better customer insights. And as we welcome 2024, let's do so with open hearts and minds, ready to embrace whatever it brings. Happy New Year, everyone!

Sales 64

Sales Sales Strategy Ethics Media 64

European Pharmaceutical Review

APRIL 29, 2024

Here, Parviz Shamlou, Senior Vice President, Science and Technology at Abzena, explores how the evolution of bioconjugation technology is leading to therapeutic advancements in oncology and beyond. Interested in bioprocessing/bioproduction?

Manufacturing 59

Manufacturing Leads Pharmaceutical 59

Pharmaceutical Commerce

OCTOBER 10, 2024

Lucy Alexander, capabilities lead, global supply chain and strategy, AstraZeneca, discusses critical conversations that supply chain teams and partners must partake in during API sourcing at LogiPharma USA 2024.

Leads 59

Leads 59

PM360

DECEMBER 20, 2024

Clients report double-digit improvements in patient adherence and onboarding, with one Brand Lead noting, 9 out of 10 of our patients on therapy were saved or accelerated by Courier Health. In July 2024, Courier Health secured $16.5

Customer Relationship Management 52

Customer Relationship Management CRM Biopharma Relationship management 52

European Pharmaceutical Review

JUNE 10, 2024

The first industrial-scale pharmaceutical manufacturing facility for production of lead-212-based radioligand therapies has been inaugurated. This news follows the company beginning construction on a similar facility in France , which is set to produce lead-212 radioligand therapies for the European market. billion.

Manufacturing 98

Manufacturing Distribution Pharmaceutical manufacturing Leads 98

European Pharmaceutical Review

JUNE 13, 2024

Tell us about Ocugen’s lead programme, OCU400. In April 2024, Ocugen received US Food and Drug Administration (FDA) clearance to initiate the Phase III liMeliGhT clinical trial for OCU400 for retinitis pigmentosa. In May 2024, Ocugen announced the second cohort (medium dose) completed dosing in the dose-escalation phase.

Manufacturing 145

Manufacturing Food and Drug Administration Engineering Safety 145

PM360

FEBRUARY 12, 2024

This trial model, in turn, leads to more sucess with better data collection and more diverse treatment options.

Food and Drug Administration 105

Food and Drug Administration Patients Medical Networking 105

European Pharmaceutical Review

JUNE 4, 2024

Meeting the Divisions at ACHEMA 2024 IMA Active The ideal partner for each solid dose processing phase: granulation, tableting, capsule filling and banding, weight checking, coating, handling and washing. They create the conditions for the next innovation, the next level of flexibility, solutions designed to enhance the value of your product.

Pharmaceutical 95

Pharmaceutical Pharma Manufacturing Training 95

Authentic Influence Group

SEPTEMBER 16, 2024

The Silent Edge: How Body Language and Communication Skills Shape Leadership Success October 9, 2024 | 8:00 AM | NYC Free Event | Limited to 30 Seats Enjoy a Breakfast Bagel | Take in the NYC Skyline | Master Leadership Through Body Language Harness the power of what’s not being said. Extraversion: Lead confidently in any setting.

Consulting 130

Consulting Competition Training Leads 130

World of DTC Marketing

DECEMBER 4, 2020

SUMMARY: McKinsey estimates that global digital-health revenues—from telemedicine, online pharmacies, wearable devices, and so on—will rise from $350bn last year to $600bn in 2024. The result of all this is that digital health is blazing trails, many of which will lead to a dead end. I’m not so sure. That is unacceptable.

Medicine 201

Medicine Doctors Medical Media 201

Clarivate

MARCH 6, 2024

For 13 years, Clarivate has identified the organizations leading the world in technology research and innovation. As the pace of innovation continues to accelerate and competition intensifies, we introduce the Top 100 Global Innovators 2024. 2024 report key findings Samsung Electronics ranks first in the Top 100 Global Innovators 2024.

Electronics 52

Electronics Competition Media Leads 52

Pharmaceutical Commerce

OCTOBER 9, 2024

Lucy Alexander, capabilities lead, global supply chain and strategy, AstraZeneca, discusses key takeaways from the breakout session at LogiPharma USA 2024.

Leads 52

Leads 52

Curzon Consulting

OCTOBER 17, 2024

17th October 2024 2 Minutes Curzon Consulting is thrilled to sponsor this year’s Alliance Manchester Business School Consultancy Case Competition. Introduced in 2016, the competition enables AMBS MBA students to showcase their skills, innovative thinking, and problem-solving abilities.

Competition 52

Competition Consulting Recruitment Government 52

Pharmaceutical Technology

MAY 2, 2024

Mergers and acquisitions (M&As) in the biopharmaceutical industry involving companies developing drugs showed a 20% increase in total deal volume in the first quarter (Q1) of 2024 compared to Q1 2023, according to leading data and analytics company GlobalData’s Pharma Intelligence Center Deals Database.

Pharma 52

Pharma Leads 52

Eversana Intouch

MARCH 15, 2024

In a recent article published by Med Ad News and PharmaLive.com , Hattie Stearns, Senior Director of Experience DesignOps, provides five key takeaways she observed as a brand and design lead at SXSW 2024.

Marketing 103

Marketing Leads Healthcare Healthcare 103

European Pharmaceutical Review

MAY 27, 2024

These new findings, which are part of an ongoing Phase II study , will be presented at the 2024 American Society of Clinical Oncology (ASCO) meeting and the European Hematology Association ( Abstract #6503 ). The study is assessing patients treated with cyclophosphamide and peripheral blood stem cell (PBSC) transplantation.

Side effects 111

Side effects Leads Patients Pharmaceutical 111

European Pharmaceutical Review

NOVEMBER 21, 2023

Phase III trials of a low carbon version of GSK’s metered dose inhaler, Ventolin (salbutamol), using a next generation, lower carbon propellant, are set to start in 2024. Dosing of first patients is planned in the first half of 2024. The post GSK propels its progress to Net Zero appeared first on European Pharmaceutical Review.

Manufacturing 116

Manufacturing Patients Pharma Leads 116

European Pharmaceutical Review

OCTOBER 28, 2024

These Phase III results were presented at the American College of Gastroenterology (ACG) 2024 conference. Novel biologic could offer ulcerative colitis symptomatic remission The post ACG 2024: J&J data reveals new Crohn’s treatment option appeared first on European Pharmaceutical Review.

Medicine 59

Medicine Patients Management Leads 59

European Pharmaceutical Review

APRIL 2, 2024

Wienand will join the contract development and manufacturing organisation (CDMO) in the summer of 2024. Wolfgang Wienand – leading the next chapter “Wolfgang brings a wealth of knowledge and experience to Lonza, complemented by his deep scientific and strategic expertise. billion.

Biopharma 98

Biopharma Leads Manufacturing Pharmaceutical 98

Pharma Marketing Network

JUNE 18, 2024

This October you will engage with leading pharma executives and patient advocates to learn first-hand how to drive change that will build a brighter and more inclusive future in healthcare. Register Here The post Reuters Events: Pharma & Patient USA | October 15-16, 2024 appeared first on Pharma Marketing Network.

Pharma 52

Pharma Patients Networking Healthcare 52

European Pharmaceutical Review

APRIL 17, 2024

Roche multiple sclerosis subcutaneous injection: late-breaking data “Updated results from OCARINA II further underline the potential benefits of subcutaneous OCREVUS for patients with both relapsing and progressive forms of MS,” shared Scott Newsome , DO, lead author, Johns Hopkins University School of Medicine.

Food and Drug Administration 93

Food and Drug Administration Safety Medicine Food 93

PM360

DECEMBER 20, 2024

Volta Medical One in four adults over 40 years old are at risk for developing atrial fibrillation (AF), a condition that can lead to blood clots, stroke, heart failures, and other heart-related complications. AF, when left untreated, doubles the risk of heart-related deaths and is associated with a 5-fold increased risk for stroke.

Medical 52

Medical Healthcare Healthcare Leads 52

PM360

FEBRUARY 23, 2024

TEAM MEMBERS: Katrina Gary Senior Director of Patient Marketing Alyson McNamara Associate Director of Patient Marketing Dan Pedersen Director Andrew Prahin Creative Director Sam Hoar Lead Copywriter Parker Gibson Lead Art Director Marisa Gurovski Account Lead OTHER BROTHER TEAM MEMBERS: Stuart Bury Executive Creative Director, Other Brother Isaiah (..)

Education 52

Education Pharma Leads Marketing 52

European Pharmaceutical Review

JULY 29, 2024

The post CHMP meeting highlights – July 2024 appeared first on European Pharmaceutical Review. The CHMP’s opinion is based on data from Phase III clinical data.

Medicine 52

Medicine Marketing Leads Pharmaceutical 52